Displaying drugs 15201 - 15225 of 15774 in total
Liprotamase protease
Experimental
Pygeum africanum bark
Experimental
Artemisia annua leaf
Experimental
Fucus vesiculosus
Experimental
Zagotenemab
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
Investigational
Lanacogene vosiparvovec
Experimental
Volrubigene ralaparvovec
Volrubigene ralaparvovec is under investigation in clinical trial NCT03223194 (Gene Transfer Clinical Study in Crigler-najjar Syndrome).
Investigational
Ezaladcigene resoparvovec
Investigational
Avalotcagene ontaparvovec
Investigational
Bomtabegagene bavoparvovec
Investigational
Verbrinacogene setparvovec
Investigational
Botaretigene sparoparvovec
Investigational
NeuroVax
Investigational
GL-2045
Investigational
Latozinemab
Investigational
BLS-M22
Investigational
TSHA-118
TSHA-118 is a self-complementary AAV9 gene replacement therapy designed to express a human codon-optimized CLN1 transgene for the treatment of CLN1 disease.
Experimental
PR006
PR006 is a non-replicating recombinant adeno-associated virus serotype 9 containing the progranulin gene. It is being investigated for the treatment of dementia.
Investigational
BMN-044
Experimental
Withdrawn
BMN-046
Experimental
Withdrawn
Alirinetide
Investigational
BMN-055
Experimental
Withdrawn
MTI-201
Investigational
Murlentamab
Investigational
Lerapolturev
Investigational
Displaying drugs 15201 - 15225 of 15774 in total